These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 5131472)

  • 1. [Possibility of enhancing the endogenous inactivation of corticosteroid hormones].
    Rummel' AG; Krass PM; Kogan AS
    Dokl Akad Nauk SSSR; 1971; 201(4):1004-5. PubMed ID: 5131472
    [No Abstract]   [Full Text] [Related]  

  • 2. Salt, water and adrenal steroid metabolism.
    Wolfman EF; Kowalczyk RS; Trevino G
    Major Probl Clin Surg; 1964; 1():152-75. PubMed ID: 4949990
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effect of progesterone on the metabolism of corticosteroid hormones in the lymphocytes and hepatocytes of rats with adjuvant disease].
    Pytskiĭ VI; Gulyĭ IuL; Baliakin IuV
    Patol Fiziol Eksp Ter; 1983; (4):25-9. PubMed ID: 6634221
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effect of portalization of blood outflowing from the adrenal glands on the development of secondary hyperaldosteronism and ascites].
    Kogan AS; Vlasov IuA; Kuz'mina VN; Lomivorotov VN; Rummel' AG
    Biull Eksp Biol Med; 1971 Aug; 72(8):31-3. PubMed ID: 5112523
    [No Abstract]   [Full Text] [Related]  

  • 5. ["Portalization" of the blood outflow from the adrenals for the purpose of enhancing corticosteroid metabolism (a review of the Soviet and foreign literature)].
    Kogan AS; Gonchar AM
    Vestn Khir Im I I Grek; 1981 Feb; 126(2):134-9. PubMed ID: 7233709
    [No Abstract]   [Full Text] [Related]  

  • 6. Experimental, clinical, and metabolic results of side-to-side portacaval shunt for intractable cirrhotic ascites.
    Orloff MJ; Orloff MS; Orloff SL; Girard B
    J Am Coll Surg; 1997 Jun; 184(6):557-70. PubMed ID: 9179111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influencing hormone inactivation by surgery.
    Leveen HH; Diaz CA; Piccone VA; Douglass HO; Falk G
    Bull Soc Int Chir; 1970; 29(6):381-6. PubMed ID: 5512909
    [No Abstract]   [Full Text] [Related]  

  • 8. Endogenous origin of the humoral agent responsible for gastric hypersecretion associated with portacaval shunt.
    Villar-Valdes H; Thompson AG; Rosen H; Chandler JG; Orloff MJ
    Surg Forum; 1969; 20():360-2. PubMed ID: 5383087
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of a monoamine oxidase inhibitor on blood ammonia and gastric secretion in dogs: II. Dogs with side-to-side and end-to-side portacaval anastomosis.
    Kowalewski K; Bondar GF
    Can J Surg; 1966 Jan; 9(1):99-103. PubMed ID: 5900272
    [No Abstract]   [Full Text] [Related]  

  • 10. The "H-graft" in portacaval shunt in dogs.
    Grga A; Maticić Z; Hlevnjak D; Hofman B
    Mater Med Pol; 1994; 26(3):109-12. PubMed ID: 7603080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatotrophic influence of portal venous blood.
    Welborn MB; Lanier VC; Foster JH
    Surg Forum; 1966; 17():381-3. PubMed ID: 5920972
    [No Abstract]   [Full Text] [Related]  

  • 12. [On the problem of total arterialization of the liver].
    Brunner E; Kucsko L; Kühlmayer R; Wense G
    Wien Z Inn Med; 1966 Jan; 47(1):17-25. PubMed ID: 5973612
    [No Abstract]   [Full Text] [Related]  

  • 13. The effect of portacaval transposition on renal and adrenal function.
    Mito M; Pikula JV; McDermott WV
    Surg Gynecol Obstet; 1966 Dec; 123(6):1289-96. PubMed ID: 5953962
    [No Abstract]   [Full Text] [Related]  

  • 14. [Reverse experimental portocaval anestomosis].
    Bazhenov VS; Perlin VS
    Eksp Khir Anesteziol; 1967; 12(2):38-9. PubMed ID: 5617615
    [No Abstract]   [Full Text] [Related]  

  • 15. [Corticosteroid hormones: mechanisms involved in the recognition of aldosterone by mineralocorticoid receptors].
    Hellal-Levy C; Fagart J; Souque A; Rafestin-Oblin ME
    J Soc Biol; 1999; 193(4-5):355-60. PubMed ID: 10689617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Site of origin of the hormone responsible for gastric hypersecretion associated with portacaval shunt.
    Orloff MJ; Villar-Valdes H; Abbott AG; Williams RJ; Rosen H
    Surgery; 1970 Jul; 68(1):202-7; discussion 207-8. PubMed ID: 10483470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The metabolic response of the liver to portacaval shunt.
    Smith GW; Mouzas GL
    Br J Surg; 1969 Aug; 56(8):627. PubMed ID: 5797767
    [No Abstract]   [Full Text] [Related]  

  • 18. Hepatic morphologic changes following end-to-side portacaval shunt in dogs.
    Lanier VC; Buchanan RD; Foster JH
    Am Surg; 1968 Mar; 34(3):185-95. PubMed ID: 5638502
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effect of formalin stress on the corticoid fractions of rat organs and tissues].
    Fazekas IG; Fazekas AT
    Endokrinologie; 1968 Feb; 52(5):315-26. PubMed ID: 5703792
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effects of portacaval shunt on gastric secretion in cirrhotic dogs].
    Storace R
    Chir Patol Sper; 1965; 13(5):178-82. PubMed ID: 5887290
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.